SBK1 (SH3-binding kinase 1) is a serine/threonine kinase that is involved in various cellular processes, including cell signaling, cell migration, and inflammation. As a kinase, SBK1 phosphorylates specific substrates, which can alter their activity, localization, or interaction with other proteins, thereby influencing cellular pathways and responses. Its role is particularly noted in the regulation of cytoskeletal rearrangement and cellular motility, which are crucial for processes such as tissue development, wound healing, and immune cell trafficking. The modulation of these functions by SBK1 suggests its importance in maintaining cellular dynamics and homeostasis. Additionally, SBK1 has been implicated in the signaling pathways that control inflammation, highlighting its potential role in immune responses and pathological conditions where inflammation is a key feature.
The activation of SBK1 is tightly regulated at multiple levels to ensure its appropriate action within signaling networks. Primarily, SBK1 activation is dependent on its phosphorylation status, which can be influenced by upstream kinases that respond to various cellular stimuli, including growth factors, cytokines, and environmental stressors. Phosphorylation typically activates SBK1, enabling it to subsequently phosphorylate its downstream targets. This activation can be further modulated by localization signals within SBK1 that direct the kinase to specific cellular compartments where its substrates are located. Additionally, the interaction of SBK1 with other proteins, such as those containing SH3 domains, can influence its activity and specificity. These protein-protein interactions not only help stabilize SBK1 in its active form but also serve to integrate SBK1 activity into broader signaling pathways, thus ensuring that its kinase activity is exerted in a context-specific manner. Such precise regulation of SBK1 activity is essential for the coordinated modulation of cellular functions in response to internal and external cues, playing a vital role in the dynamic adaptation of cells to their changing environments.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Olomoucine | 101622-51-9 | sc-3509 sc-3509A | 5 mg 25 mg | $72.00 $274.00 | 12 | |
CDK inhibitor that perturbs cell cycle progression. A halted cell cycle can lead to cellular stress, activating SBK1 as part of the stress response pathway. | ||||||
Roscovitine | 186692-46-6 | sc-24002 sc-24002A | 1 mg 5 mg | $94.00 $265.00 | 42 | |
Another CDK inhibitor that interrupts cell cycle regulation. The interruption may activate SBK1 as a compensatory mechanism for cell cycle modulation. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
PI3K inhibitor that interferes with cell survival pathways. The suppression of PI3K can activate SBK1 as an alternate survival pathway. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
Another MEK inhibitor that interferes with MAPK signaling. The altered MAPK pathway can cause cells to rely on SBK1 for cell cycle regulation. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
JNK inhibitor that changes stress response signaling. With JNK inhibited, SBK1 can be activated as an alternative mechanism for stress response. | ||||||
BAPTA/AM | 126150-97-8 | sc-202488 sc-202488A | 25 mg 100 mg | $138.00 $458.00 | 61 | |
Calcium chelator that disrupts calcium signaling. Reduced intracellular calcium levels can activate SBK1 to modulate apoptosis as calcium is vital for many pro-apoptotic functions. | ||||||
Nocodazole | 31430-18-9 | sc-3518B sc-3518 sc-3518C sc-3518A | 5 mg 10 mg 25 mg 50 mg | $59.00 $85.00 $143.00 $247.00 | 38 | |
Microtubule depolymerizing agent that interferes with cell division. The altered microtubule dynamics can cause the cell to utilize SBK1 for compensatory cell cycle regulation. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Another PI3K inhibitor that disrupts cell survival pathways. The inhibition of PI3K can activate SBK1 for an alternative survival strategy. | ||||||
ZM-447439 | 331771-20-1 | sc-200696 sc-200696A | 1 mg 10 mg | $153.00 $356.00 | 15 | |
Aurora kinase inhibitor disrupting chromosome alignment and segregation. The interference in cell cycle can lead to activation of SBK1 as a compensatory route for cell cycle regulation. | ||||||
2-APB | 524-95-8 | sc-201487 sc-201487A | 20 mg 100 mg | $28.00 $53.00 | 37 | |
IP3 receptor antagonist affecting calcium release from the endoplasmic reticulum. Inhibition of calcium release can activate SBK1 to modulate cellular apoptosis. | ||||||